Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
There is a clear distinction between a peripheral neuropathy that is clinically significant and which is a presenting feature of the underlying condition (e.g. those associated with diabetes mellitus, lymphoma, and uremia) and a peripheral neuropathy that is asymptomatic and detected only by careful neurologic examination and electrophysiologic studies. Peripheral polyneuropathy is frequently asymptomatic in children with systemic disorders. This chapter reviews some of the relatively uncommon but clinically significant polyneuropathies that may be encountered in pediatric patients with various systemic illnesses. A summary of these neuropathies is provided in Table 22.1 . Neuropathies seen in response to infections and metabolic and neurodegenerative disorders are also part of systemic processes, but these are described in other chapters.
Systemic Disease | Predominant Neuropathy Type a | Onset and Course | Pathology |
---|---|---|---|
Metabolic Disorders | |||
Uremia b | Sensory (sensorimotor) | Chronic (acute) | AD, SD |
Hypoglycemia | Motor | Chronic | AD |
Endocrine Disorders | |||
Hypothyroidism | Sensory | Chronic | AD |
Acromegaly | Sensory | Chronic | AD |
Diabetes mellitus b | Sensory, motor | Chronic | AD, SD |
Malignancies and Reticuloses | |||
Carcinoma | Sensory, sensorimotor | Subacute or chronic | AD (SD in acute relapsing type) |
Lymphoma b | Sensorimotor | Acute, subacute | AD, SD (acute relapsing type) |
Chronic lymphatic leukemia | Sensorimotor | Acute (subacute) | AD |
Deficiency States | |||
Vitamin B12 b | Sensory | Chronic | AD |
Thiamine b | Sensorimotor | Chronic | AD |
Folic acid | Sensory | Chronic | AD |
Vitamin E b | Sensory | Chronic | AD |
Connective Tissue Disorders | |||
Rheumatoid arthritis b | Sensory, mononeuritis | Chronic, acute | SD, AD |
Polyarteritis nodosa b | Mononeuritis | Acute, chronic | AD, SD |
Systemic lupus erythematosus b | Sensory, motor | Chronic, acute | AD, SD |
Miscellaneous | |||
Chronic liver disease b | Sensory (sensorimotor) | Chronic | AD, SD |
Primary biliary cirrhosis b | Sensory | Chronic | AD |
Viral hepatitis | Sensory or sensorimotor | Acute | SD |
Celiac disease b | Sensorimotor | Chronic | AD |
Chronic obstructive lung disease | Sensory (sensorimotor) | Chronic | AD |
Sarcoidosis b | Sensorimotor, motor | Acute or chronic | AD |
Amyloidosis b | Sensorimotor | Chronic | AD |
Paraproteinemias and Dysproteinemias | |||
Multiple myeloma | Sensorimotor (sensory) | Chronic | AD |
Cryoglobulinemia | Sensorimotor | Chronic | AD |
Macroglobulinemia | Sensorimotor | Subacute or chronic | AD, SD |
Monoclonal Gammopathy | |||
IgA | Sensorimotor | Chronic | AD |
IgG | Sensorimotor | Chronic | AD, SD |
IgM | Sensorimotor | Chronic | SD |
Critical illness polyneuropathy (CIP) occurs in patients with sepsis, asthma, organ transplantation, and multiple organ failure as part of a systemic inflammatory response syndrome (see Chapter 50 ). Initially reported in adults with severe systemic illnesses in intensive care units, it is often first recognized when it proves difficult to wean a child from mechanical ventilation. The accompanying signs of generalized weakness, muscle wasting, and depressed or absent reflexes may be difficult to detect or misinterpreted in the intensive care setting. Onset may manifest as early as within the first week of illness, with a range of 4 to 26 days documented. The differential diagnosis includes paraparesis or tetraparesis secondary to spinal cord lesions, prolonged neuromuscular blockade, steroid- or relaxant-induced myopathy, acute necrotizing myopathy, hypophosphatemia, toxic and thiamine-deficiency neuropathies, asthma-amyotrophy (Hopkins’) syndrome, and Guillain-Barré syndrome ( Box 22.1 ). A similar condition may occasionally follow severe burns. A careful and systematic investigation includes testing of the serum creatine kinase, which is normal in most cases, magnesium and phosphate levels, neurophysiologic studies (nerve conduction studies, electromyography [EMG], and occasionally electroencephalography), and relevant imaging modalities. If diagnostic doubt persists, nerve and/or muscle biopsy sometimes provide diagnostic information. In typical cases of critical illness polyneuropathy, nerve conduction studies and histopathologic observations confirm widespread axonal degeneration with extensive muscle denervation.
Spinal cord lesions
Prolonged neuromuscular blockade
Steroid or relaxant-induced myopathy
Acute necrotizing myopathy
Hypophosphatemia, hypermagnesemia
Toxic and thiamine-deficiency neuropathies
Asthma-amyotrophy (Hopkins’) syndrome
Guillain-Barré syndrome
CIP and critical illness myopathy are on a continuum of neuromuscular disorders. While far more data are available on affected adult patients, the limited studies in the pediatric age group suggest that the condition causes significant morbidity in critically ill children. Treatment is mainly supportive, but early correction of abnormal osmolar states, glycemic levels, and electrolyte imbalance is considered important, as well as early mobilization. Recovery, where reported, is spontaneous and of variable timing. See Case Example 22.1 .
An 18-month-old boy with Down syndrome, global developmental delay, epilepsy, and cortical blindness was admitted for septicemia and multiorgan failure. He had previously had recurrent aspiration pneumonia necessitating a fundoplication and gastrostomy, and a urinary tract infection. He received antibiotics (ceftriaxone, vancomycin, and gentamicin) as well as corticosteroids. He required massive inotropic support (adrenaline, dopamine, and dobutamine), platelets, fresh frozen plasma, and colloid infusions to stabilize his condition. Various metabolic and electrolyte problems were corrected. Hypoglycemic episodes developed, requiring glucose infusions.
Two weeks after admission, he developed an adult respiratory distress-like syndrome and was started on prednisone (2 mg/kg/day). He was slowly weaned from the ventilator but continued to have episodes of central apnea and hypercapnea. Alveolar lavage showed persistent Pseudomonas colonization. Ceftazidime and gentamicin were administered. Recurrent seizures necessitated treatment with multiple anticonvulsants. He developed generalized weakness with minimal movements limited to his left arm. The muscle stretch reflexes were absent. A cranial computed tomography scan demonstrated generalized cortical atrophy with diffuse white matter changes compatible with a hypoxic insult. An electroencephalogram was nondiagnostic. Cervical spine radiographs were unremarkable. Based on his stormy clinical course, the persistent difficulty weaning him from the ventilator, and his associated apneic spells during sleep, a diagnosis of critical illness polyneuropathy was considered.
Motor nerve conduction studies demonstrated findings consistent with an axonal polyneuropathy with markedly reduced compound muscle action potential amplitudes on all motor studies in the upper limbs, and an absent common peroneal motor response. Needle EMG of the tibialis anterior and biceps brachii muscles demonstrated fibrillations.
Although he had some improvement, he was still bedridden owing to weakness 3 months after the onset of his illness.
This is a fairly typical course for a child with critical illness polyneuropathy.
The neuropathy of chronic renal failure is typically an axonal degenerative type, which in most children is asymptomatic. Nerve conduction studies in long-term hemodialysis-dependent children generally show normal or only mildly impaired values. The evaluation of the “H” reflex has been reported as a useful indicator of clinically asymptomatic uremic polyneuropathy, identifying this complication in almost 60% of one series of children with chronic renal failure.
This neuropathy usually remains stable or improves with treatment; if not, increasing the frequency and duration of dialysis may result in improvement. Rapid improvement usually follows successful renal transplantation, even in patients with long-standing neuropathy.
Diabetic neuropathy may manifest as a polyneuropathy, focal neuropathy, or autonomic neuropathy. The latter is the most common and has the most serious side effects, related to unawareness of hypoglycemia and cardiovascular dysfunction. Children with a length-dependent polyneuropathy suffer distal sensory loss (numbness) and paraesthesiae; they may also have pain manifesting as burning, aching, and electric-sharp sensations. Weakness, clumsiness, loss of balance, and falls may be associated with distal anhidrosis, postprandial bloating, constipation, diarrhea, and lack of awareness of hypoglycemia. Glove and stocking sensory loss, loss of deep tendon reflexes, distal weakness, and even foot ulcers may occur.
Between 10% and 68% of children with diabetes suffer from neuropathies. In one large cohort of 146 children (under 18 years of age) with diabetes, 27.4% had peripheral neuropathy. Of this affected group, 62.5% had subclinical disease, a minority being clinically affected.
Although patients with diabetic neuropathy may not complain of it, their physical examination may reveal variable degrees of sensory loss. In one study, 30.8% of subjects had numbness and about 7% to 10% showed large myelinated nerve fiber dysfunction, while only 1.4% had impairment in pain or temperature sensation. Nerve conduction studies most often show abnormalities of the peroneal and sural nerves.
Large studies have suggested that neuropathy can develop in young children with short illness duration and despite good glycemic control. As such, the concept of the duration of illness as a key disease-inducing factor has not been established; it has been suggested that the nerve damage can occur acutely and rapidly at the onset of the diabetes, subsequent to which the neuropathy develops more slowly or may even plateau. The best way to prevent this complication is still strict blood glucose control.
Since the neuropathy can progress and ultimately affect quality of life, but is often initially subclinical, regular nerve conduction studies are recommended in order to monitor for development of this serious disease complication.
Multiple endocrine neoplasia (MEN) type 2B is a rare, dominantly inherited syndrome accounting for 5% of all cases of MEN 2, characterized by medullary thyroid carcinoma, pheochromocytoma, ganglioneuromatosis, and a variety of skeletal and connective tissue abnormalities. MEN 2B cases usually carry either an M918T or A883T mutation of the RET (REarranged during Transfection) oncogene. Affected patients have an arresting appearance because of a diffuse, thick, fleshy enlargement of the everted lips, apparent eversion of the eyelids, and a marfanoid habitus. Other oral manifestations include a high arched palate and small, whitish-yellow, firm, protruding neuromatous nodules on the tongue. Fibular atrophy, pes cavus, scoliosis, and proximal or distal muscle atrophy are common.
A polyneuropathy, with mild weakness of ankle dorsiflexion or occasionally of the intrinsic hand muscles, may be the presenting manifestation of this disorder. Nerve conduction studies demonstrate mild abnormalities of motor and sensory nerve conduction. Chronic denervation is apparent on needle EMG.
Sural nerve biopsy reveals moderate loss of small- and large-diameter myelinated fibers. At autopsy, unusual plaques of hyperplastic interlacing bands of Schwann cells and myelinated fibers overlie the posterior columns of the spinal cord. Autonomic nerves are also involved and are responsible for the severe constipation or diarrhea frequently seen in these patients.
Early diagnosis is extremely important because of the high risk of malignancy. Medullary thyroid carcinoma is almost always present at the time of diagnosis.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here